THERACLION
Research THERACLION (ALTHE.PA) on Bullrun: market cap EUR 53.81M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALTHE.PA
- ExchangeALXP
- CountryFrance
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 53.81M
- Financial periodFY2025
- RevenueEUR 1.19M
- Revenue growth42.9%
- Net income-EUR 5.69M
- Free cash flow-EUR 7.16M
- Gross margin-240.8%
Valuation Snapshot
latest market cap is EUR 53.81M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 1.19M | -EUR 5.69M | -EUR 7.16M | -240.8% | -0.1 | EUR 1.88M | EUR 4.94M | -EUR 2.59M |
| FY2024 | EUR 830.00K | -EUR 5.76M | -EUR 1.96M | -345.9% | -0.12 | EUR 4.17M | EUR 1.30M | -EUR 114 |
| FY2023 | EUR 1.82M | -EUR 3.68M | -EUR 2.60M | -59.3% | -0.08 | EUR 7.82M | EUR 1.95M | EUR 5.65M |
| FY2022 | EUR 1.24M | -EUR 4.96M | -EUR 5.59M | -246.9% | -0.17 | EUR 2.49M | EUR 2.51M | EUR 544.87K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-05 | EUR 53.81M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About THERACLION
Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is THERACLION's market cap?
THERACLION's market capitalization is EUR 53.81M.
What does THERACLION do?
Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.